Cipher Pharmaceuticals (OTCMKTS:CPHRF) Stock Passes Below Fifty Day Moving Average – Here’s Why

Shares of Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) (TSE:CPH) crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $11.15 and traded as low as $10.75. Cipher Pharmaceuticals shares last traded at $10.81, with a volume of 36,856 shares traded.

Cipher Pharmaceuticals Stock Performance

The company’s 50 day simple moving average is $11.15 and its two-hundred day simple moving average is $9.84.

About Cipher Pharmaceuticals

Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome.